Updates

INDIA GLYCOLS LIMITED Plot No. 2-8, Sector - 126, NOIDA-201304, Distt. Gautam Budh Nagar (Uttar Pradesh). Tel. : +91 (120) 6860000, 3090100, 3090200 Fax : +91 (120) 3090111, 3090211, E-mail : igiho@indiaglycols.com, Website : www.indiaglycols.com IGL/SE/2026-27/48 21+ August, 2026 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1# Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Mumbai - 400 001 Bandra (East), Mumbai- 400 051 Scrip Code: 500201 Symbol: INDIAGLYCO Dear Sirs, Sub.: Material Update in Connection with Ennature Bio Pharma Limited with reference to Observation letter no. NSE/LIST/48932 dated 17t November, 2025 and no. DCS/AMAL/TS/R37/3905/2025-26 dated 19" November, 2025 ("Observation Letters”), issued by the National Stock Exchange of India Limited and BSE Limited (collectively the "Stock Exchanges”), respectively, received in relation to the Scheme of Arrangement. With reference to captioned above, we would like to inform you that Ennature Bio Pharma Limited (“EBL"), through ifs letter dated 21 August, 2026, has communicated to the Company certain material events/ updates in relation fo EBL, which is enclosed herein as Annexure A. This disclosure is being made in respect of EBL, pursuant to the requirement in the Observation Letters and SEBI Master Circular No. HO/4911 411 4(7)2025-CFD-POD211 13762/2026 dated 30" January, 2026 (as amended). You are requested to kindly take the same on record. Thanking you, Yours faithfully, For India Glycols Limited Ankur Jain Head (Legal) & Company Secretary Encl: A/a Corporate Office : 3A, Shakespeare Sarani, Kolkata - 700071, Phone : +91 33 22823585, 22823586 Works & Registered Office : A-1, Industrial Area, Bazpur Road, Kashipur - 244713, Distt. Udham Singh Nagar (Uttarakhand) Phone : +91 5947 269000 / 269500 Fax : +91 5947 275315, 269535 CIN : L24111UR1983PLC009097 AnnexureA ENNATURE BIO PHARMA LIMITED (Formerly known as Ennature Bio Pharma Private Limited) Plot No. 2-B, Sector-126, Noida- 201304, Distt. Gautam Budh Nagar, Uttar Pradesh, Tel.: +91 120 3090100, 3090200, 6860000 Fax: +91 120 3090111, 30902111 E-mail: connect@ennature.com; Website: www.ennaturebiopharma.com 21% August, 2026 India Glycols Limited Plot No. 2-B, Sector- 126, Noida-201304 Sub: Material update in connection with the Scheme of Arrangement amongst India Glycols Limited and Ennature Bio Pharma Limited (the Company) and IGL Spirits Limited and their respective shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ("Scheme"). Dear Sirs, This is to inform you that the Board of Directors of the Company, at its meeting held on 21% August, 2026, has inter- alia, approved the appointment of following Directors and Key Managerial Personnel (KMP) of the Company: 1. Ms. Pragya Bhartia Barwale (DIN: 02109262) as Managing Director (Key Managerial Personnel) of the Company for a period of 5 (Five) years w.e.f. 21% August, 2026, subject to the approval of the shareholders. 2. Mr. US. Bhartia (DIN:00063091) as Additional Director (Non- Executive) w.e.f. 21*' August, 2026, subject to the approval of the shareholders. 3. Ms. Pooja Jhaver (DIN: 02109201) as Additional Director (Non- Executive) w.e.f. 21 August, 2026, subject to the approval of the shareholders. 4. Mr. Malay Memani (DIN: 09537408) as Additional Director, in the category of Independent Directoorf the Company for a term of 3 (three) years w.e.f. 21%* August, 2026 till 20" August 2029, subject to the approval of the shareholders. 5. Ms. Shukla Wassan (DIN: 02770898) as Additional Director, in the category of Independent Director of the Company for a term of 3 (three) years w.e.f. 21" August, 2026 till 20" August 2029, subject to the approval of the shareholders. 6. Ms. Bharati Agarwal (DIN: 10252447) as Additional Director, in the category of Independent Director of the Company for a term of 3 (three) years w.e.f. 21% August, 2026 till 20" August 2029, subject to the approval of the shareholders. 7. Ms. Shilpa Divakar Nirula (DIN: 06619353) as Additional Director, in the category of Independent Director of the Company for a term of 3 (three) years w.e.f. 21 August, 2026 till 20" August 2029, subject to the approval of the shareholders. Registered Office: P.No. 4, Pharma City, Selaqui-248197, Dehradun, Uttarakhand, India Phone: +91 135-2698620, Fax: +91 135 2698939; CiN: U24290UR2021PLC013005 ENNATURE BIO PHARMA LIMITED (Formerly known as Ennature Bio Pharma Private Limited) Plot No. 2-B, Sector-126, Noida- 201304, Distt. Gautam Budh Nagar, Uttar Pradesh, Tel.: +91 120 3090100, 3090200, 6860000 Fax: +91120 3090111, 30902111 E-mail: connect@ennature.com; Website: www.ennaturebiopharma.com It is affirmed that all the above appointed Directors are not debarred from holding the office of Director by virtue of any SEBI order or any other such authority in terms of BSE Circular LIST/COMP/14/2018-19 and NSE Circular NSE/CML/2018/24 dated 20" June, 2018. Necessary details as required under Master Circular No. HO/49/14114(7)2025-CFD- POD2/}/3762/2026 dated 30" January, 2026 are enclosed herewith as Annexure A. This is for your information. Thanking You. Yours faithfully, For Ennature flq;fi‘arma Limited Miiish Chahdra Pant Director Encl: As above Registered Office: P.No. 4, Pharma City, Selaqui-248197, Dehradun, Uttarakhand, India Phone: +91 135-2698620, Fax: +91 135 2698939; CIN: U24290UR2021PLC013005 ENNATURE BIO PHARMA LIMITED (Formerly known as Ennature Bio Pharma Private Limited) Plot No. 2-B, Sector-126, Noida- 201304, Distt. Gautam Budh Nagar, Uttar Pradesh, Tel.: +91 120 3090100, 3090200, 6860000 Fax: +91 120 3090111, 30902111 E-mail: connect@ennature.com; Website: www.ennaturebiopharma.com Annexure-A Sr No Particulars Ms. Pragya Bhartia Barwale (DIN: 02109262) 1 Reason for change (appointment, | Ms. Pragya Bhartia Barwale (DIN: 02109262) has been appointed as igRateR; L—death Additional Director (Managing Director) & Key Managerial Personnel otherwise) 2 Date of appointment and term of | w.e.f. 21% August 2026 for a period of 5 (five) years till 20™ August 2031. appointment 3 Brief profile Ms. Pragya Bhartia Barwale aged 44 years holds a Bachelor of Arts degree (in case of appointment) in Economics and International Relations from Brown University, USA and a Master of Science degree in Development Economics from the University of Oxford, U.K. She has a rich experience of over 18 years encompassing various aspects of the business including Strategic Planning, Technology and Project Management. She has been successfully leading the business operations of Ennature Biopharma division of IGL, driving it to achieve a revenue of over Rs. 200 Crores. She has played a pivotal role in identifying strategic growth opportunities and steering the division’s expansion into the high-margin Branded Nutraceutical Ingredients segment. By prioritizing investment in R & D and clinical science for new product development, she has significantly reduced the division's reliance on traditional plant-based APIs and nicotine & its derivatives. 4 Disclosure of relationships between | Ms. Pragya Bhartia Barwale is related to Mr. U.S. Bhartia as daughter directors and Ms. Pooja Jhaver as sister (in case of appointment of a director) Sr No Particulars Mr. U.S. Bhartia (DIN:00063091) 1 Reason for change (appointment, | Mr. U.S. Bhartia (DIN: 00063091) has been appointed as Additional igRation; —death Director (Non- Executive) 2 Date of appointment and term of w.e.f. 21% August 2026 appointment 3 Brief profile Shri U.S. Bhartia aged 72 years is a Bachelor of Commerce with Honours (in case of appointment) from Calcutta University. He is an industrialist with rich and diverse experience of over four decades in managing various types of industries. Shri Bhartia has been awarded the lifetime achievement award in Business leadership for the India Chemi [Showing first 8,000 characters — download PDF for full document]